Atovaquone/Proguanil Hydrochloride Tablets Manufacturer & Supplier PAN India
Trusted Manufacturer & Supplier of Atovaquone/Proguanil Hydrochloride Tablets in India
Taj Pharma is a leading PAN India manufacturer and supplier of Atovaquone/Proguanil Hydrochloride Tablets, offering quality pharmaceutical solutions that meet global healthcare standards. With manufacturing units based in Vapi, Gujarat, and a robust distribution network in Mumbai, Maharashtra, we cater to both domestic and international pharmaceutical markets.
We are known for our GMP-compliant, high-efficacy antimalarial formulations, designed for the treatment and prevention of malaria caused by Plasmodium falciparum, including drug-resistant strains. Our products are manufactured under the strictest quality protocols and are widely exported to regions such as Africa, the Middle East, and LATAM.
Comprehensive PAN India Presence – PCD Pharma Franchise & Third-Party Manufacturing
We provide PCD Pharma Franchise opportunities and third-party manufacturing services for Atovaquone/Proguanil Hydrochloride Tablets throughout India. Our franchise partners benefit from:
- Monopoly rights in their territory
- Competitive pricing
- Free promotional tools
- Full product training and support
- Quick and efficient logistics
We aim to empower distributors and marketing professionals through transparent business practices and consistent product availability.
Best Price for Atovaquone/Proguanil HCI Tablets in Mumbai, Maharashtra
Taj Pharma offers the best price in Mumbai, Maharashtra for bulk orders of Atovaquone/Proguanil HCI Tablets, without compromising on quality. By utilizing cost-effective manufacturing and supply chain optimization, we are able to provide premium antimalarial products at industry-leading rates.
Our product pricing is ideal for:
- Government tenders
- NGOs and healthcare programs
- Hospitals and clinics
- Retail and wholesale distributors
- International procurement agencies
What Sets Taj Pharma Apart as a Manufacturer of Atovaquone/Proguanil Tablets
WHO-GMP & ISO Certified Manufacturing
All our products, including Atovaquone/Proguanil Hydrochloride Tablets, are manufactured at WHO-GMP, ISO 9001:2015-certified facilities. These globally recognized certifications ensure that every batch meets the highest standards in:
- Quality assurance
- Sterility
- Bioavailability
- Stability
- Regulatory compliance
Regulatory Support and Export Documentation
We supply a complete set of regulatory documents for global markets:
- Certificate of Analysis (COA)
- Certificate of Pharmaceutical Product (COPP)
- CTD/ACTD Dossiers
- Stability Data
- Product Master File
Our regulatory expertise supports swift product registrations in both regulated and semi-regulated markets.
Wide Range of Dosage Strengths and Packaging
We manufacture Atovaquone/Proguanil HCI Tablets in various strengths suitable for both adult and pediatric use. Our packaging is designed for optimal storage and global shipping, including:
- Blister packs (Alu-Alu and PVC)
- Secondary printed cartons
- Bulk packaging for hospitals and tenders
Efficient Distribution Across India and Export Markets
Our extensive logistics network ensures PAN India delivery, with rapid dispatch capabilities from Mumbai and Gujarat. We serve key Indian cities and regions including:
- Delhi NCR
- Hyderabad
- Bangalore
- Chennai
- Kolkata
- Ahmedabad
- Pune
Globally, we export to:
- Nigeria
- Kenya
- Ghana
- South Africa
- UAE
- Saudi Arabia
- Colombia
- Peru
- Brazil
Therapeutic Indications of Atovaquone/Proguanil Hydrochloride Tablets
Atovaquone/Proguanil is a combination antimalarial medication that provides superior efficacy in:
- Malaria Prophylaxis: Used by travelers and patients entering malaria-endemic regions
- Malaria Treatment: Effective against acute, uncomplicated malaria caused by P. falciparum
- Resistant Malaria: Suitable for areas with chloroquine- and sulfadoxine-pyrimethamine resistance
Dosage and Administration Guidelines
- Prophylactic Dose (Adult): One tablet daily, beginning 1-2 days before entering the endemic region and continued for 7 days post-exposure
- Therapeutic Dose (Adult): One tablet daily for three consecutive days
- Pediatric Dose: Based on body weight; available in lower strength formulations
Important Note: These tablets should be taken with a high-fat meal or drink to maximize absorption.
Storage and Handling
- Store at 20°C to 25°C (68°F to 77°F)
- Temporary exposure permitted between 15°C to 30°C
- Protect from excessive heat, humidity, and direct sunlight
- Do not remove tablets from blister packaging until use
Common Side Effects
Most patients tolerate Atovaquone/Proguanil Hydrochloride Tablets well. Some may experience:
- Nausea or vomiting
- Abdominal pain
- Diarrhea
- Dizziness
- Headache
- Mouth ulcers
- Vivid dreams or insomnia
Patients are advised to consult their physician in case of persistent side effects or allergic reactions.
The #1 Choice for Global Antimalarial Procurement
As a top-tier manufacturer and exporter of Atovaquone/Proguanil HCI Tablets, Taj Pharma is your one-stop solution for:
- Ethical and branded formulations
- Institutional supply
- International NGO procurement
- Contract manufacturing
- Franchise-based distribution
We bring together decades of industry experience, advanced R&D, and global certifications to ensure unmatched product quality and client satisfaction.
Partner With Us Today
If you are a pharmaceutical distributor, government buyer, hospital, or NGO looking for a reliable source for Atovaquone/Proguanil Hydrochloride Tablets, choose Taj Pharma. With our extensive expertise, streamlined logistics, and competitive pricing, we ensure a seamless experience from inquiry to delivery.
